Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> WHO’s Funding Must be Diversified To Prevent Repeat Of Budget Crisis Triggered By US Withdrawal, Say Executive Board Members 21/01/2021 Paul Adepoju Reform and diversification of the World Health Organization’s (WHO) funding model is vital if the global health body is to avoid repeating the consequences of the US’s withdrawal in April 2020, member states have said during WHO’s Executive Board meetings. The global COVID-19 pandemic has magnified the “open secret” within the field of global health […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> Pfizer Temporarily Reduces EU Vaccine Deliveries, While US President Biden’ Vaccine Plan Dubbed ‘Aspirational’ But ‘Doable’ 15/01/2021 J Hacker Deliveries of the Pfizer/BioNTech vaccine to all European Union (EU) states will be reduced for an undisclosed period starting from next week, Norway’s National Institute of Public Health has said. The sudden change to delivery schedules, Pfizer announced on Friday, is due to a reorganization of the company’s production capacity. It did not say how […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> WHO’s Funding Must be Diversified To Prevent Repeat Of Budget Crisis Triggered By US Withdrawal, Say Executive Board Members 21/01/2021 Paul Adepoju Reform and diversification of the World Health Organization’s (WHO) funding model is vital if the global health body is to avoid repeating the consequences of the US’s withdrawal in April 2020, member states have said during WHO’s Executive Board meetings. The global COVID-19 pandemic has magnified the “open secret” within the field of global health […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> Pfizer Temporarily Reduces EU Vaccine Deliveries, While US President Biden’ Vaccine Plan Dubbed ‘Aspirational’ But ‘Doable’ 15/01/2021 J Hacker Deliveries of the Pfizer/BioNTech vaccine to all European Union (EU) states will be reduced for an undisclosed period starting from next week, Norway’s National Institute of Public Health has said. The sudden change to delivery schedules, Pfizer announced on Friday, is due to a reorganization of the company’s production capacity. It did not say how […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> WHO’s Funding Must be Diversified To Prevent Repeat Of Budget Crisis Triggered By US Withdrawal, Say Executive Board Members 21/01/2021 Paul Adepoju Reform and diversification of the World Health Organization’s (WHO) funding model is vital if the global health body is to avoid repeating the consequences of the US’s withdrawal in April 2020, member states have said during WHO’s Executive Board meetings. The global COVID-19 pandemic has magnified the “open secret” within the field of global health […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> Pfizer Temporarily Reduces EU Vaccine Deliveries, While US President Biden’ Vaccine Plan Dubbed ‘Aspirational’ But ‘Doable’ 15/01/2021 J Hacker Deliveries of the Pfizer/BioNTech vaccine to all European Union (EU) states will be reduced for an undisclosed period starting from next week, Norway’s National Institute of Public Health has said. The sudden change to delivery schedules, Pfizer announced on Friday, is due to a reorganization of the company’s production capacity. It did not say how […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> WHO’s Funding Must be Diversified To Prevent Repeat Of Budget Crisis Triggered By US Withdrawal, Say Executive Board Members 21/01/2021 Paul Adepoju Reform and diversification of the World Health Organization’s (WHO) funding model is vital if the global health body is to avoid repeating the consequences of the US’s withdrawal in April 2020, member states have said during WHO’s Executive Board meetings. The global COVID-19 pandemic has magnified the “open secret” within the field of global health […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> Pfizer Temporarily Reduces EU Vaccine Deliveries, While US President Biden’ Vaccine Plan Dubbed ‘Aspirational’ But ‘Doable’ 15/01/2021 J Hacker Deliveries of the Pfizer/BioNTech vaccine to all European Union (EU) states will be reduced for an undisclosed period starting from next week, Norway’s National Institute of Public Health has said. The sudden change to delivery schedules, Pfizer announced on Friday, is due to a reorganization of the company’s production capacity. It did not say how […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> WHO’s Funding Must be Diversified To Prevent Repeat Of Budget Crisis Triggered By US Withdrawal, Say Executive Board Members 21/01/2021 Paul Adepoju Reform and diversification of the World Health Organization’s (WHO) funding model is vital if the global health body is to avoid repeating the consequences of the US’s withdrawal in April 2020, member states have said during WHO’s Executive Board meetings. The global COVID-19 pandemic has magnified the “open secret” within the field of global health […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> Pfizer Temporarily Reduces EU Vaccine Deliveries, While US President Biden’ Vaccine Plan Dubbed ‘Aspirational’ But ‘Doable’ 15/01/2021 J Hacker Deliveries of the Pfizer/BioNTech vaccine to all European Union (EU) states will be reduced for an undisclosed period starting from next week, Norway’s National Institute of Public Health has said. The sudden change to delivery schedules, Pfizer announced on Friday, is due to a reorganization of the company’s production capacity. It did not say how […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO’s Funding Must be Diversified To Prevent Repeat Of Budget Crisis Triggered By US Withdrawal, Say Executive Board Members 21/01/2021 Paul Adepoju Reform and diversification of the World Health Organization’s (WHO) funding model is vital if the global health body is to avoid repeating the consequences of the US’s withdrawal in April 2020, member states have said during WHO’s Executive Board meetings. The global COVID-19 pandemic has magnified the “open secret” within the field of global health […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> Pfizer Temporarily Reduces EU Vaccine Deliveries, While US President Biden’ Vaccine Plan Dubbed ‘Aspirational’ But ‘Doable’ 15/01/2021 J Hacker Deliveries of the Pfizer/BioNTech vaccine to all European Union (EU) states will be reduced for an undisclosed period starting from next week, Norway’s National Institute of Public Health has said. The sudden change to delivery schedules, Pfizer announced on Friday, is due to a reorganization of the company’s production capacity. It did not say how […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> Pfizer Temporarily Reduces EU Vaccine Deliveries, While US President Biden’ Vaccine Plan Dubbed ‘Aspirational’ But ‘Doable’ 15/01/2021 J Hacker Deliveries of the Pfizer/BioNTech vaccine to all European Union (EU) states will be reduced for an undisclosed period starting from next week, Norway’s National Institute of Public Health has said. The sudden change to delivery schedules, Pfizer announced on Friday, is due to a reorganization of the company’s production capacity. It did not say how […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer Temporarily Reduces EU Vaccine Deliveries, While US President Biden’ Vaccine Plan Dubbed ‘Aspirational’ But ‘Doable’ 15/01/2021 J Hacker Deliveries of the Pfizer/BioNTech vaccine to all European Union (EU) states will be reduced for an undisclosed period starting from next week, Norway’s National Institute of Public Health has said. The sudden change to delivery schedules, Pfizer announced on Friday, is due to a reorganization of the company’s production capacity. It did not say how […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Posts navigation Older postsNewer posts